Je was op zoek naar: bronchiseptica (Lithouws - Engels)

bronchiseptica sukeltus simptomus.
nobivac bb was the first live b. bronchiseptica vaccine licensed for use in cats.

-inaktyvuot bordetella bronchiseptica lsteli
-inactivated bordetella bronchiseptica cells.

pasteurella multocida ir bordetella bronchiseptica
pasteurella multocida and bordetella bronchiseptica

bronchiseptica galima naudoti ir sunims.
vaccines against b. bronchiseptica that are administered through the nose are also used in dogs.

skatina susidaryti aktyvų imunitetą bordetella bronchiseptica.
to stimulate active immunity against bordetella bronchiseptica.

bordetella bronchiseptica in vitro natraliai nejautri ceftiofurui.
bordetella bronchiseptica is inherently insensitive to ceftiofur in vitro.

vienoje dozje 106, 3­108, 3 kfv bordetella bronchiseptica.
106,3 and 108,3 cfu/dose b. bronchiseptica

vienoje dozėje 106, 3– 108, 3 kfv bordetella bronchiseptica.
≥ 106,3 and ≤ 108,3 cfu/ dose b. bronchiseptica

inaktyvuotų bordetella bronchiseptica ląstelių ≥ 5,5 log2 agl. titras2
 5.5 log2 agglutination titre2 inactivated bordetella bronchiseptica cells

gyva vakcina katms nuo bordetella bronchiseptica sukeliamos kvpavimo tak ligos.
live vaccine against feline upper respiratory tract disease caused by bordetella bronchiseptica.

-inaktyvuot bordetella bronchiseptica lsteli 4, 2 log2 agl. titras 2.
dermonecrotic toxin) 4.2 log 2 aggl. titre2-inactivated bordetella bronchiseptica cells.

gyva vakcina nuo kaci virsutini kvpavimo tak ligos, sukeliamos bordetella bronchiseptica.
live vaccine against feline upper respiratory tract disease caused by bordetella bronchiseptica.

106, 3­108, 3 kfv gyv b-c2 paderms bordetella bronchiseptica bakterij.
106,3 and 108,3 cfu of live bordetella bronchiseptica bacteria strain b-c2.

dažniausiai bordetella bronchiseptica sudaro sąlygas nosies gleivinės paviršiaus kolonizacijai pasteurella multocida.
colonisation of the surface of the nasal mucosa by pasteurella multocida is most often promoted by bordetella bronchiseptica.

106, 3– 108, 3 kfv gyvų b- c2 padermės bordetella bronchiseptica bakterijų.
per 0.2 ml dose of reconstituted suspension: ≥ 106,3 and ≤ 108,3 cfu of live bordetella bronchiseptica bacteria strain b-c2.

dazniausiai bordetella bronchiseptica sudaro slygas nosies gleivins pavirsiuje vystytis pasteurella multocida bakterijomis.
colonisation of the surface of the nasal mucosa by pasteurella multocida is most often promoted by bordetella bronchiseptica.

nobivac bb ­ tai vakcina, kurios sudtyje yra gyv b-c2 paderms bakterij bordetella bronchiseptica.
nobivac bb is a vaccine that contains a live bacterium bordetella bronchiseptica strain b-c2.

nobivac bb – tai vakcina, kurios sudėtyje yra gyvų b- c2 padermės bakterijų bordetella bronchiseptica.
nobivac bb is a vaccine that contains a live bacterium bordetella bronchiseptica strain b-c2.

siuose tyrimuose kiekvienos parsaveds kiekvienos vados parseli kraujo mginiuose buvo ieskoma antikn pries pasteurella multocida toksin ir bordetella bronchiseptica.
in this study, blood was taken from piglets in each litter born from each sow, and tested for antibodies to pasteurella multocida toxin and bordetella bronchiseptica.

1 mėn. amžiaus kačiukams ir vyresnėms katėms imunizuoti, norint sumažinti bordetella bronchiseptica sukeliamos kvėpavimo takų ligos klinikinius požymius.
for active immunisation of cats, of 1 month of age or older to reduce clinical signs of bordetella bronchiseptica associated upper respiratory tract disease.